title: Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits.
authors.forename: Thórunn
authors.initials: T
authors.lastname: Jónsdóttir
authors.forename: Birgitta
authors.initials: B
authors.lastname: Sundelin
authors.forename: Elisabet
authors.initials: E
authors.lastname: Welin Henriksson
authors.forename: Ronald F
authors.initials: RF
authors.lastname: van Vollenhoven
authors.forename: Iva
authors.initials: I
authors.lastname: Gunnarsson
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D050533:Glomerular Basement Membrane / Q000648:ultrastructure; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy*; D008854:Microscopy, Electron; D000069283:Rituximab; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide